Clinical trials
Terminated Phase 1/2 Metabolic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2016 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Baylor College of Medicine | 1 |
| Diva De Leon | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| REGENXBIO Inc. | 1 |
| SwanBio Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 5 |
| Adrenal Insufficiency | 1 |
| Adrenoleukodystrophy | 1 |
| Albinism | 1 |
| Albinism, Oculocutaneous | 1 |
| Atherosclerosis | 1 |
| Brain Diseases, Metabolic | 1 |
| Brain Diseases, Metabolic, Inborn | 1 |
| Cardiovascular Diseases | 1 |
| Congenital Hyperinsulinism | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.